Corporate Sustainability as a Competitive Strategy in Brazilian Companies
نویسندگان
چکیده
منابع مشابه
Do Japanese companies have a competitive strategy ?
Responding to Michael Porter’s claim that “Japanese companies rarely have a strategy”, this paper argues that the competitive advantage of Japanese enterprises is not to be found in traditional practices. Rather it is due to the way these practices are upgraded and reinforced by ideological factors such as the “community of fate”, as well as the formation of governance structures that cultivate...
متن کاملCorporate Sustainability as a Business Strategy in SMEs - A Literature Review in the Emerging Market Context
Corporate Sustainability is well practiced and communicated in big corporate houses. Also among SMEs in developed European market socially and environmentally responsible behaviour is to some extent evident. However in case of SMEs in emerging markets of Asia, Africa and Latin America the sustainability practices of the companies are totally unorganised and informal. This paper does a comparati...
متن کاملFrom Competitive Advantage to Corporate Strategy
Recognizing past diversification mistakes, some companies have initiated large-scale restructuring programs. Others have done nothing at all. Whatever the response, the strategic questions persist. Those who have restructured must decide what to do next to avoid repeating the past; those who have done nothing must awake to their vulnerability. To survive, companies must understand what good cor...
متن کاملA Study in Brazilian Companies
The approach used to implement an ERP system is an important decision in its implementation project as it greatly affects the configuration of the system, the allocation of resources and the management of the project and its risks. It will also play a decisive role at all the stages of the ERP system’s life cycle. This chapter discusses the different ways of “goinglive” of ERP systems: big-bang...
متن کاملBiosimilars as a strategy to improve sustainability
It is clearly acknowledged that competition between branded drugs and lower impact strategies (biosimilars and generics) might potentially represent a key driver to bend cancer-cost curve in the forthcoming future. In this regard, regulatory agencies (European Medicines Agency (EMA) and Food and Drug Administration) moved towards developing a specific pathway for the approval of biosimilars, al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal for Innovation Education and Research
سال: 2019
ISSN: 2411-2933,2411-3123
DOI: 10.31686/ijier.vol7.iss4.1397